Meetings
39th Meeting of the British Society
for Paediatric Endocrinology and Diabetes
for Paediatric Endocrinology and Diabetes
BSPED Meeting Plan
| 9 Nov 2011 | |||
| 16:00 17:30 | Main Meeting Registration | ||
| 17:30 19:00 | Sanofi-Aventis Satellite Symposium Satellite Symposium Programme (pdf)(1.18mb)” | ||
| 19:00 19:45 | Welcome Reception | ||
| 19:45 | Speakers Dinner by invitation only Novo Nordisk | ||
| 10 Nov 2011 | |||
| 08:50 09:00 | Welcome Chair: Mehul Dattani | ||
| 09:00 10:30 | Oral Communications 1 Chairs: Helen Spoudea & Sabah Alvi | ||
| 09:00 | OC1.1 OC1.1 | Surgical treatment of children with hyperparathyroidism: single centre experience Presenter: S Alagaratnam, (London) | |
| 09:11 | OC1.2 OC1.2 | Isolation and characterisation of tumorigenic progenitors/stem cells with a stabilizing mutation in beta-catenin, in a mouse model of human adamantinomatous craniopharyngioma. Presenter: C L Andoniadou, (London) | |
| 09:22 | OC1.3 OC1.3 | High likelihood of malignancy in patients presenting with a thyroid nodule Presenter: F Jamil, (Newcastle upon Tyne) | |
| 09:33 | OC1.4 OC1.4 | Growth Retardation and Severe Constipation due to the first human, dominant negative Thyroid Hormone Receptor Alpha mutation Presenter: N Schoenmakers, (Cambridge) | |
| 09:44 | OC1.5 OC1.5 | DECONVOLUTION ANALYSIS OF 24H SERUM CORTISOL PROFILES INFORMS THE AMOUNT AND DISTRIBUTION OF HYDROCORTSIONE REPLACEMENT THERAPY Presenter: P Hindmarsh, (London) | |
| 09:55 | OC1.6 OC1.6 | Twenty novel mutations in nicotinamide nucleotide transhydrogenase (NNT) causing FGD Presenter: L Metherell, | |
| 10:06 | OC1.7 OC1.7 | Mild GH deficiency due to two novel homozygous mutations in the gene encoding Growth-Hormone Releasing Hormone receptor (GHRHR) in a single family Presenter: L C Gregory, (London) | |
| 10:17 | OC1.8 OC1.8 | Mutations in PROKR2 but not PROK2 are associated with congenital hypopituitarism and septo-optic dysplasia Presenter: M McCabe, (London) | |
| 10:30 11:00 | Coffee | ||
| 11:00 12:30 | Symposium 1 – Update on Adrenal Disorders Chair: John Gregory | ||
| 11:00 | S16 S16 | Familial Glucocorticoid Deficiency: An Update Adrian Clark, | |
| 11:30 | S17 S17 | Recent advances in our understanding of adrenal disease and development John Achermann, | |
| 12:00 | S18 S18 | Health problems in Congenital Adrenal Hyperplasia – a UK perspective Nils Krone, | |
| 12:30 14:00 | Lunch | ||
| 13:15 14:00 | Poster Tour | ||
| 14:00 15:00 | Oral Communications 2 - Brief Communications Chairs: Wolfgang Hogler & Caroline Brain | ||
| 14:00 | OC2.1 OC2.1 | Sperm cryopreservation in adolescent minors with cancer: factors predicting pre-treatment semen quality in 79 minors aged 12-18 years over 10 years Presenter: H W Gan, (London) | |
| 14:06 | OC2.2 OC2.2 | The assessment of bone microarchitecture by high resolution magnetic resonance imaging (micro MRI) in young adults with childhood onset disease Presenter: C Yacoubian, (Glasgow) | |
| 14:12 | OC2.3 OC2.3 | MCM4 mutation causes a novel DNA replication disorder associated with short stature and adrenal failure Presenter: C Hughes, (London) | |
| 14:18 | OC2.4 OC2.4 | Short Term Effects of Recombinant IGF-I therapy in children with Laron’s Syndrome. Presenter: N Amin, (Leeds) | |
| 14:24 | OC2.5 OC2.5 | A selective effect of IGFBP-3 on brain volumes in healthy children Presenter: E Webb, (London) | |
| 14:30 | OC2.6 OC2.6 | What defines Vitamin D deficiency biochemically in children? Presenter: N Atapattu, (Birmingham) | |
| 14:36 | OC2.7 OC2.7 | Selective reduction in trabecular bone mineral density during treatment for childhood acute lymphoblastic leukaemia Presenter: R Sands (Southampton), | |
| 14:42 | OC2.8 OC2.8 | Novel SOX2 mutation: from clinical phenotype to identification of new molecular mechanisms of SOX2 action and interactions. Presenter: K Alatzoglou (London), | |
| 15:00 15:30 | Tea | ||
| 15:30 16:30 | Symposium 2 – Pubertal Disorders Chairs: Mehul Dattani & Liz Crowne | ||
| 15:30 | S19 S19 | Novel insights into Hypogonadotrophic Hypogonadism Nelly Pitteloud, | |
| 16:00 | S20 S20 | Management of Delayed Puberty Leo Dunkel, | |
| 16:45 18:00 | BSPED Annual General Meeting | ||
| 19:45 20:15 | Pre-dinner Welcome Reception | ||
| 20:15 | Conference Dinner | ||
| 11 Nov 2011 | |||
| 09:00 10:00 | Symposium 3 – Novel therapies/management in Diabetes Mellitus Chairs: Peter Hindmarsh & James Greening | ||
| 09:00 | S21 S21 | Insulin resistance syndromes Rob Semple, | |
| 09:30 | S22 S22 | Use of insulin for the early treatment of Type 2 Diabetes Mellitus Rury Holman, | |
| 10:00 10:30 | BSPED Research Award winners presentation from 2010 Tim Cheetham | ||
| 10:20 10:30 | BSPED Website Launch Justin Davies | ||
| 10:30 11:00 | Coffee | ||
| 11:00 11:45 | Plenary Guest Lecture: Advances in our understanding of the Genetic Causes of Obesity Sadaaf Farooqi | ||
| 11:45 12:30 | Oral Communications 3 - Brief Communications Chairs: Tabitha Randell & Rakesh Amin | ||
| 11:45 | OC3.1 OC3.1 | The impact of growth hormone deficiency (GHD) and growth hormone treatment (GHTx) on the cardiovascular risk in survivors of bone marrow transplantation with total body irradiation (BMT/TBI) in childhood Presenter: N Davis (Southampton), | |
| 11:56 | OC3.2 OC3.2 | Clinical, genetic, histological and radiological heterogeneity of focal forms of congenital hyperinsulinism Presenter: D Ismail (London), | |
| 12:07 | OC3.3 OC3.3 | Laparoscopic near total pancreatectomy for medically unresponsive diffuse congenital hyperinsulinism Presenter: A Pierro (London), | |
| 12:18 | OC3.4 OC3.4 | The heterogeneity of hyperinsulinaemic hypoglycaemia in 19 patients with Beckwith-Wiedemann syndrome due to KvDMR1 hypomethylation. Presenter: D Ismail (London), | |
| 12:30 13:30 | Lunch | ||
| 13:30 14:15 | Oral Communications 4 - Brief Communications Chairs: Tabitha Randell & Rakesh Amin | ||
| 13:30 | OC4.1 OC4.1 | Ethnicity Rather Than Deprivation Impacts on Diabetes Control and use of Treatment Regimen Presenter: R Thompson (London), | |
| 13:41 | OC4.2 OC4.2 | White UK children are older, more obese and more insulin resistant than non-White UK children at diagnosis of type 2 diabetes: baseline results of the UK national Type 2 diabetes cohort. Presenter: T Barrett (Birmingham), | |
| 13:52 | OC4.3 OC4.3 | Non-linear Dynamic Analysis of Glucose Regulation in Subjects with Type 2 Diabetes and Controls - Observed Variability and Liability (OVAL) Presenter: P Hindmarsh (London), | |
| 14:03 | OC4.4 OC4.4 | Natural history of background retinopathy in children and young people with diabetes Presenter: A Karthikeyan (Birmingham), | |
| 14:15 15:55 | Symposium 4 – Insulin Resistance and Type 2 Diabetes: Novel Insights Chairs: David Dunger & Jeremy Kirk | ||
| 14:15 | S24 S24 | Islet cell transplantation: an update Peter Jones, | |
| 14:45 | S25 S25 | Immunology of Type 1 Diabetes Mellitus Mark Peakman, | |
| 15:15 | S26 S26 | Update on closed loop systems for the treatment of Type 1 DM Roman Havorka, | |
| 15:55 | Close of Meeting | ||
In this section..
Welcome note
Abstract submission instructions
Accommodation
Annual dinner
Conference secretariat and contact
Programme and Abstract Book
CME Training Day Programme
Main Meeting Scientific Programme
PDSN Programme
Endocrine Nurse Programme
Main Meeting Registration
CME Training Day Registration
Prizes
Venue
Sponsors and Exhibitors
